Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Sep;29(3):401-7.

Malaria antigen-specific T-cell responsiveness during infection with Plasmodium falciparum

Malaria antigen-specific T-cell responsiveness during infection with Plasmodium falciparum

D J Wyler et al. Clin Exp Immunol. 1977 Sep.

Abstract

Protective immunity against Plasmodium falciparum develops only after several years of repeated exposure to the malarial parasite. We therefore investigated the possibility that acute malaria was associated with malarial antigen-specific immunosuppression. Peripheral lymphocytes of West Africans with and without P. falciparum infections were tested for their in vitro proliferative responses to a preparation of P. falciparum antigen. There was no significant difference between the magnitude of the proliferative response of lymphocytes from infected as compared to normal Africans, although the responses from both African groups were significantly higher than responses from a group of European controls. Furthermore, no soluble inhibitor of antigen-specific proliferation was present in plasma of infected patients. These observations strongly suggest that if the sluggish development of protective immunity in malaria is based upon infection-related immunosuppression, this occurs without affecting the proliferative responsiveness of specific sensitized, circulating T cells. Preliminary observations also indicate that Europeans residing in Africa and taking malaria prophylaxis may acquire sensitized T cells without experiencing clinically apparent infections.

PubMed Disclaimer

References

    1. Br Med J. 1956 Sep 22;2(4994):686-92 - PubMed
    1. Lancet. 1970 Nov 28;2(7683):1114-6 - PubMed
    1. Lancet. 1972 Jan 22;1(7743):169-72 - PubMed
    1. J Exp Med. 1972 Aug 1;136(2):207-15 - PubMed
    1. Lancet. 1969 Aug 2;2(7614):246-7 - PubMed

LinkOut - more resources